Abstract
Autism spectrum disorder (ASD) is an inherited neurodevelopmental disorder of social communication and restricted, repetitive behaviors. Much remains unknown about their mechanisms of action and physiological effects. In recent years, there has been a growing interest in nutritional diets, which can be used as a form of therapeutic intervention for ASD with a recent increase in the research being carried out in this field. Selective nutrition therapy for ASD and brain function shows improvement in behavioral changes and reduction in malnutrition seemingly associated with the allergies or food intolerances to gluten. Therefore, a gluten-free diet has yielded positive outcomes giving hope in developing therapy for ASD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Volkmar, F. R., Reichow, B., Westphal, A., & Mandell, D. S. (2014). Autism and the autism spectrum: Diagnostic concepts. In F. R. Volkmar (Ed.), Handbook of autism and pervasive developmental disorders (4th ed.). Hoboken, NJ: Wiley. https://doi.org/10.1002/9781118911389.hautc01
Tsatsanis, K. D., Volkmar, F. R., Paul, R., Klin, A., & Cohen, D. (2014). Neuropsychological characteristics in autism and related conditions. In F. R. Volkmar, R. Paul, A. Klin, & D. Cohen (Eds.), Handbook of autism and pervasive developmental disorders: Diagnosis, development, neurobiology, and behavior (Vol. 1, 3rd ed., pp. 365–381). Hoboken, NJ: Wiley. https://doi.org/10.1002/9780470939345.ch13
McCarthy, J., Hemmings, C., Kravariti, E., Dworzynski, K., Holt, G., Bouras, N., et al. (2010). Challenging behavior and co-morbid psychopathology in adults with intellectual disability and autism spectrum disorders. Research in Developmental Disabilities, 31(2), 362–366.
Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36(8), 1101–1114.
Bourgeron, T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nature Reviews. Neuroscience, 16, 551–563.
Ronemus, M., Iossifov, I., Levy, D., & Wigler, M. (2014). The role of de novo mutations in the genetics of autism spectrum disorders. Nature Reviews. Genetics, 15, 133–141.
Arora, N. K., MKC, N., Gulati, S., Deshmukh, V., Mohapatra, A., Mishra, D., et al. (2018). Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in India. PLoS Medicine, 15, e1002615.
Almeida, M. I., Reis, R. M., & Calin, G. A. (2011). MicroRNA history: Discovery, recent applications, and next frontiers. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 717, 1–8.
Pickles, A., Bolton, P., Macdonald, H., Bailey, A., Le Couteur, A., Sim, C. H., et al. (1995). Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: A twin and family history study of autism. American Journal of Human Genetics, 57(3), 717.
Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., et al. (2014). Most genetic risk for autism resides with common variation. Nature Genetics, 46(8), 881–885. https://doi.org/10.1038/ng.3039
Basu, S. N., Kollu, R., & Banerjee-Basu, S. (2009). AutDB: A gene reference resource for autism research. Nucleic Acids Research, 37, D832–D836. https://doi.org/10.1093/nar/gkn835
Penn, H. E. (2006). Neurobiological correlates of autism: A review of recent research. Child Neuropsychology, 12(1), 5779. https://doi.org/10.1080/09297040500253546
Hsiao, E. Y. (2013). Immune dysregulation in autism spectrum disorder. Neurobiology of autism. International Review of Neurobiology., 113, 269–302. https://doi.org/10.1016/B978-0-12-418700-9.00009-5
Levy, S. E., Mandell, D. S., & Schultz, R. T. (2009). Autism. Lancet, 374(9701), 1627–1638. https://doi.org/10.1016/S0140-6736(09)61376-3
Löscher, W. (2002). Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs, 16, 669–694.
Meador, K., Reynolds, M. W., Crean, S., Fahrbach, K., & Probst, C. (2008). Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Research, 81, 1–13.
Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B., & Hersh, J. H. (2001). Fetal valproate syndrome and autism: Additional evidence of an association. Developmental Medicine and Child Neurology, 43, 202–206.
Christensen, J., Gronborg, T. K., Sorensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., et al. (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA, 309, 1696–1703.
Miller, M. T. (1991). Thalidomide embryopathy: A model for the study of congenital incomitant horizontal strabismus. Transactions of the American Ophthalmological Society, 81, 623–674.
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., et al. (2010). Identification of a primary target of thalidomide teratogenicity. Science, 327, 1345–1350.
Narita, N., Kato, M., Tazoe, M., Miyazaki, K., Narita, M., & Okado, N. (2002). Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: Putative animal models for autism. Pediatric Research, 52, 576–579.
Gonzalez, C. H., Marques-Dias, M. J., Kim, C. A., Sugayama, S. M., Da Paz, J. A., Huson, S. M., et al. (1998). Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet, 351, 1624–1627.
MacFabe, D. F., Cain, D. P., Rodriguez-Capote, K., Franklin, A. E., Hoffman, J. E., Boon, F., et al. (2007). Neurobiological effects of intraventricular propionic acid in rats possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behavioural Brain Research, 176, 149–169.
Reith, R. M., McKenna, J., Wu, H., Hashmi, S. S., Cho, S. H., Dash, P. K., et al. (2013). Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Neurobiology of Disease, 51, 93–103.
Moy, S. S., Riddick, N. V., Nikolova, V. D., Teng, B. L., Agster, K. L., Nonneman, R. J., et al. (2014). Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism. Behavioural Brain Research, 259, 200–214.
Valicenti-McDermott, M., McVicar, K., Rapin, I., Wershil, B. K., Cohen, H., & Shinnar, S. (2006). Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. Journal of Developmental and Behavioral Pediatrics, 27, S128–S136.
Catassi, C., & Fasano, A. (2008). Celiac disease. Current Opinion in Gastroenterology, 24, 687–691.
Yang, A., Chen, Y., Scherl, E., Neugut, A. I., Bhagat, G., & Green, P. H. R. (2005). Inflammatory bowel disease in patients with celiac disease. Inflammatory Bowel Diseases, 11, 528–523.
Camarca, A., Anderson, R. P., Mamone, G., Fierro, O., Facchiano, A., Costantini, S., et al. (2009). Intestinal T cell response to gluten peptides are largely heterogeneous: Implications for a peptide-based therapy in celiac disease. Journal of Immunology, 182, 4158–4166.
Vojdani, J.B. Pangborn, E. Vojdani, E.L. (2003) Cooper Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol, 16, 189–199.
Elder, J. H., Shankar, M., Shuster, J., Theriaque, D., Burns, S., & Sherrill, L. (2006). The gluten-free, casein-free diet in autism: Results of a preliminary double blind clinical trial. Journal of Autism and Developmental Disorders, 36, 413–421.
Groom Jr., A. D. (2011) LusterCXCR3 in T cell function. Exp. Cell Res, 317, 620–631.
Hosomi, S., Oshitani, N., Kamata, N., Sogawa, M., Okazaki, H., Tanigawa, T., et al. (2011). Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis. Clinical & Experimental Immunology, 163, 215–224.
McCarthy, D. M., & Coleman, M. (1979). Response of intestinal mucosa to gluten challenge in autistic subjects. The Lancet, ii, 877–878.
Arnold, G. L., Hyman, S. L., Mooney, R., & Kirby, R. S. (2003). Plasma amino acids profiles in children with autism: Potential risk for nutritional deficiencies. Journal of Autism and Developmental Disorders, 33(4), 449–454.
Knivsberg, A. M., Reichelt, K. L., Hoien, T., & Nodland, M. (2002). A randomized, controlled study of dietary intervention in autistic syndromes. Nutritional Neuroscience, 5(4), 251–261.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sumathi, T., Manivasagam, T., Thenmozhi, A.J. (2020). The Role of Gluten in Autism. In: Essa, M., Qoronfleh, M. (eds) Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management. Advances in Neurobiology, vol 24. Springer, Cham. https://doi.org/10.1007/978-3-030-30402-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-30402-7_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30401-0
Online ISBN: 978-3-030-30402-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)